论文信息 - VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma - 字舞流文

VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma

B. Monk | Shin-ichiro Takahashi | V. Samouëlian | A. Oaknin | D. Lorusso | K. Tewari | A. C. de Melo | J. Pikiel | A. Lisyanskaya | A. Miller | C-L. Chang | F. Damian | J. Li | M. Fury | I. Vergote | M. Mathias | Y. Kim | E. Gotovkin | D. Ramone | H. Kim